CKD-337 Drug Interaction Study

Inclusion Criteria: * A healthy male volunteer between 19 and 55 years old. * BMI between 18.5 and 27. * Able to participate in the entire trial * Signed the informed consent form prior to study participation. Exclusion Criteria: * Clinically significant digestive system, cardiovascular system, respiratory system, endocrine system, hepatic system, renal system * sit SBP \< 100mmHg or sit SBP ≥ 150mmHg or sit DBP \< 70mmHg or sit DBP ≥ 100mmHg * Have acute infection history within 14 days * Have a allergic disease of need to treat * Have hypersensitivity reactions history for IP or any specific drugs. * AST, ALT or Total bilirubin \> UNL \* 1.5 * Estimated GFR \< 60 ml/min * Genetic problems such as galactose intolerance, Lapp lactase deficiency, glucose-galactose malabsorption * A heavy smoker (cigarette \> 10 cigarettes per day) * A heavy alcohol consumer (alcohol \> 140g/week) * A heavy grapefruit consumer (more than 1cup per a day) * Have a history of drug abuse or showed a positive for urine drug test. * Administrated IP within 60 days prior to screening * Rhabdomyolysis include of having a history or family history of genetic muscle diseases * Positive for HIV antibody, HBsAg, HCV antibody test * Previously donate whole blood within 60 days or component blood within 30 days * Subject takes ethical drug or herbal medicine within 30 days * Clinically significant laboratory test result * An impossible one who participates in clinical trial by investigator's decision including other reason